A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
26 locations incl. Little Rock
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
Adams Clinical, Philadelphia
Clinical research site in Philadelphia, Pennsylvania · 9501 ROOSEVELT BLVD STE 208, PHILADELPHIA, PA 19114-1027 · (215) 676-6696 · Website
As of July 2026, 9 paid clinical trials are recruiting at Adams Clinical, Philadelphia in Philadelphia, Pennsylvania. Active studies at this site cover conditions such as Major Depressive Disorder, Bipolar I Disorder and Schizophrenia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Adams Clinical, Philadelphia (9)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for Bipolar I Disorder
26 locations incl. Bentonville
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07494305·Phase 2·Recruiting·Listed Mar 2026
A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
32 locations incl. Little Rock
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
38 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for Major Depressive Disorder
31 locations incl. Phoenix
Sponsor: Syndeio Biosciences, Inc
Sex: All·Age: 18 - 64
Code: NCT07115329·Phase 2·Recruiting·Listed Aug 2025
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
for Major Depressive Disorder
43 locations incl. Phoenix
Sponsor: Cybin IRL Limited
Sex: All·Age: 18 - 85
Code: NCT06564818·Phase 3·Recruiting·Listed Aug 2024
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for Major Depressive Disorder (MDD)
33 locations incl. Birmingham
Sponsor: Cybin IRL Limited
Sex: All·Age: 18 - 85
Code: NCT06793397·Phase 3·Recruiting·Listed Jan 2025
A Study to Evaluate the Effect of KarXT on Urological Safety
for Schizophrenia
13 locations incl. Little Rock
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18 - 65
Code: NCT07221877·Phase 4·Recruiting·Listed Oct 2025
Triage Survey for Psychiatry Research Eligibility
for Major Depressive Disorder
6 locations incl. Boston
Sponsor: Adams Clinical
Sex: All·Age: 18+
Code: NCT05800925·Recruiting·Listed Apr 2023
More research sites in Philadelphia
- University of Pennsylvania (357 trials)
- Children's Hospital of Philadelphia (306 trials)
- Thomas Jefferson University Hospital (112 trials)
- Thomas Jefferson University (95 trials)
- Fox Chase Cancer Center (94 trials)
- Hospital of the University of Pennsylvania (87 trials)
- The Children's Hospital of Philadelphia (42 trials)
- Temple University (39 trials)
- Temple University Hospital (38 trials)
- University of Pennsylvania/Abramson Cancer Center (30 trials)
Explore more
Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials